Advanced search
Publication Cover
Postgraduate Medicine Volume 122, 2010 - Issue 5
Submit an article Journal homepage
95
Views
12
CrossRef citations to date
0
Altmetric
Clinical Focus: ADHD, Allergies, and Immunization

Does Prior Exposure to Stimulants in Children with ADHD Impact Cardiovascular Parameters from Lisdexamfetamine Dimesylate?

Sharon B. Wigal Child Development Center, Department of Pediatrics, University of California, Irvine, Irvine, CACorrespondence[email protected]
, PhD,
Angela Jun Child Development Center, Department of Pediatrics, University of California, Irvine, Irvine, CA
, FNP,
Amanda A. Wong Child Development Center, Department of Pediatrics, University of California, Irvine, Irvine, CA
, BS,
Annamarie Stehli Child Development Center, Department of Pediatrics, University of California, Irvine, Irvine, CA
, MPH,
Robin Steinberg-Epstein Child Development Center, Department of Pediatrics, University of California, Irvine, Irvine, CA
, MD &
Marc A. Lerner Child Development Center, Department of Pediatrics, University of California, Irvine, Irvine, CA
, MD
Pages 27-34 | Published online: 13 Mar 2015

References

  • . Shire US Inc. Adderall XR [package insert]. Wayne, PA: Shire US Inc; 2010
  • . McNeil Pediatrics. Concerta [package insert]. Titusville, NJ: McNeil Pediatrics; 2008
  • . Novartis Pharmaceuticals Corp. Focalin XR [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2008
  • . American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008. J Dev Behav Pediatr. 2008;29(4):335
  • . Elia J, Vetter VL. Cardiovascular effects of medications for the treatment of attention-deficit hyperactivity disorder: what is known and how should it influence prescribing in children? Paediatr Drugs. 2010;12(3):165–175
  • . Perrin JM, Friendman RA, Knilans TK; Black Box Working Group; Section on Cardiology and Cardiac Surgery. Section on cardiology and cardiac surgery. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics. 2008;122(2):451–453
  • . Greenhill LL, Findling RL, Swanson JM; ADHD Study Group. A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 2002;109(3):e39–e45
  • . Wigal SB, Wilens TE, Wolraich M, Lerner M. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results. Pediatrics. 2007;120(1):e120–e128
  • . US Food and Drug Administration. FDA approval letter. Drug approval package: Vyvanse (lisdexamfetamine dimesylate) NDA. #021977. US Food and Drug Administration. 2007. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021977s000TOC.cfm. Accessed May 29, 2009
  • . Shire US Inc. ADHD medicine: Vyvanse (lisdexamfetamine dimesylate) CII dosing information. http://www.vyvanse.com/dosing.asp. Accessed April 3, 2009
  • . Wigal SB, Maltas S, Crinella F, . Reading performance as a function of treatment with lisdexamfetamine dimesylate in elementary school children with attention deficit hyperactivity disorder. In press. J Atten Dis.
  • . Pennick M. Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatr Dis Treat. 2010;6:317–327
  • . Wigal SB, Wong AA, Jun A, Stehli A, Steinberg-Epstein R, Lerner MA. Adverse events in medication treatment naïve children with attention-deficit/hyperactivity disorder: results from a small, controlled trial of lisdexamfetamine dimesylate. In press
  • . Cascade E, Kalali AH, Wigal SB. Real-world data on attention deficit hyperactivity disorder medication side effects: expert commentary. Psychiatry. 2010;7(4):13–15
  • . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV TR). Washington, DC: American Psychiatric Association; 2000
  • . Kaufman AS, Kaufman NL. KBIT-2: Kaufman Brief Intelligence Test, Second Edition. Minneapolis, MN: NCS Pearson; 2006
  • . DuPaul GJ, Power TJ, McGoey KE, Ikeda MJ, Anastopoulos AD. ADHD Rating Scale IV: Checklists, Norms and Clinical Interpretation. New York, NY: Guilford; 1998
  • . Kaufman J, Birmaher B, Brent D, . Schedule for affective disorders and schizophrenia for school-age children present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980–988
  • . Wigal S, Wigal T. The Laboratory School Protocol: its origin, use, and new applications. J Attent Disord. 2006;10(1):92–111
  • . Wigal SB, Kollins SH, Childress AC, Squires L; 311 Study Group. A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatry Ment Health. 2009;3(1):17
  • . Biederman J, Boellner SW, Childress AC, Lopez FA, Krishnan S, Zhang Y. Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: A double-blind, placebo-controlled, crossover analog classroom study. Biol Psychiatry. 2007;62(9):970–976
  • . Biederman J, Krishnan S, Schreckengost J, Findling RL. Comparative efficacy and safety of lisdexamfetamine dimesylate in stimulant-naïve and previously treated children aged 6 to 12 years with attention-deficit/hyperactivity disorder: a secondary analysis. Abstract presented at: American Psychiatric Association Annual Meeting, May 19–24, 2007; San Diego, CA
  • . Freemantle N. Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? BMJ. 2001(7292);322:989–991

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.